TFF Pharmaceuticals, Inc.

CIK 1733413 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for TFF Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Mar 7, 2025EFFECT9999999995-25-000601
Mar 7, 2025EFFECT9999999995-25-000600
Mar 7, 2025EFFECT9999999995-25-000599
Mar 7, 2025EFFECT9999999995-25-000602
Mar 6, 2025250001213900-25-021257
Mar 6, 2025POS AM0001213900-25-021117
Mar 6, 2025POS AM0001213900-25-021115
Mar 6, 2025POS AM0001213900-25-021109
Mar 6, 2025S-8 POS0001213900-25-021236
Mar 6, 2025S-8 POS0001213900-25-021242
Mar 6, 2025POS AM0001213900-25-021116
Mar 6, 2025S-8 POS0001213900-25-021245
Mar 6, 20258-K0001213900-25-021099
Feb 4, 2025DEFA14A0001213900-25-010073
Feb 3, 20258-K0001213900-25-009477
Dec 23, 2024DEF 14A0001213900-24-111481
Dec 11, 2024PRE 14A0001213900-24-107883
Dec 10, 20248-K0001213900-24-107409
Nov 20, 202410-Q0001213900-24-100587
Nov 19, 2024SC 13G/A0001193125-24-261722
Nov 14, 2024NT 10-Q0001213900-24-098467
Nov 14, 20248-K0001213900-24-098457
Nov 14, 2024SC 13G0001172661-24-005108
Aug 14, 20248-K0001213900-24-068991
Aug 14, 202410-Q0001213900-24-068964